StockData
Immunocore Holdings plc logo

Immunocore Holdings plc (IMCR) stock

IMCRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/3015% below fair value
$27.51−0.30 (-1.08%)

Close on Nov 18, 2026Market cap $1.42BP/E –Yield 0.00%

Immunocore price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Immunocore's price to book ratio was 3.9× on Nov 11, 2026, against 5.0× a year earlier. Over the last 5 years it ranged from 0.0× to 10.3×, with a median of 4.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.9×−0.5
2025Dec 31, 20254.4×+0.5
2024Dec 31, 20243.9×−5.8
2023Dec 29, 20239.7×+9.6
2022Dec 30, 20220.1×–

More Immunocore figures

See a number that looks wrong?